Cancer remains one of the hottest areas for pharma deals and this week saw a big one: Pfizer’s proposed $11.4 billion buyout of Array Biopharma. The announcement comes less than a month after Boulder, CO-based Array announced positive data from a pivotal study of its combination drug in colorectal cancer. Array has told investors that […]
Original Article: Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More